• Dibutyryl-cAMP, Sodium Salt in Decidualization

  2026-09-29

  Explore how Dibutyryl-cAMP, sodium salt functions as a controllable cAMP stimulus in endometrial decidualization research. This article translates ACSL4 and fatty-acid β-oxidation findings into practical assay-design decisions beyond conventional cAMP pathway studies.

• L-Threonine Workflows for Metabolic Research

  2026-09-29

  L-Threonine is best used as a controlled nutrient variable for cell culture optimization, metabolic profiling, and nutritional intervention studies—not as a direct alkaline phosphatase reagent. This workflow pairs disciplined amino acid handling with a separate metal-free carbon-dot ALP assay to reduce matrix confusion and improve experimental interpretation.

• Asunaprevir (BMS-650032): HCV NS3 Inhibition

  2026-09-28

  Asunaprevir, also called BMS-650032, is a noncovalent HCV NS3 protease inhibitor with a reported enzyme IC50 of 1 nM. Product data describe genotype-spanning biochemical activity, HCV RNA replication inhibition in multiple cell types, oral efficacy, and liver-relevant disposition, while supporting research use rather than unqualified clinical extrapolation.

• Benzyl Quinolone Carboxylic Acid (BQCA): Evidence & Use

  2026-09-28

  Benzyl Quinolone Carboxylic Acid (BQCA) is a positive allosteric modulator used to investigate M1 muscarinic acetylcholine receptor signaling. Evidence supports acetylcholine potentiation and preclinical neuronal responses, but does not establish clinical benefit or a universal assay protocol.

• BQCA Workflows for M1 Receptor Signaling

  2026-09-27

  Use BQCA to probe how allosteric enhancement of M1 acetylcholine receptor signaling changes G-protein and β-arrestin responses—not simply whether a receptor turns on. This workflow-led guide combines concentration-response design, BRET-based interaction assays, and practical handling controls for cognitive and Alzheimer’s disease research.

• NBC19 for NLRP3 Inflammasome Research

  2026-09-26

  Use NBC19 to test how NLRP3 activity contributes to IL-1β release, with reported nanomolar activity in differentiated THP1 cells. A practical workflow pairs trigger-specific dose curves with viability controls—and treats cancer-associated macrophage-like cell studies as an exploratory extension, not an established application.

• GANT61 Targets the Hh–PIK3IP1–Akt Axis in ALK+ ALCL

  2026-09-25

  A 2026 study reports that the Hedgehog-pathway inhibitor GANT61 reduces proliferation and promotes cell-cycle arrest and apoptosis in ALK-positive anaplastic large cell lymphoma cell lines. The findings connect Gli1 inhibition with increased PIK3IP1 and reduced Akt phosphorylation, suggesting a signaling relationship that merits further testing rather than establishing a clinical treatment strategy.

• BQCA Workflows for M1 Receptor Signaling

  2026-09-25

  Use BQCA to separate increased acetylcholine potency from changes in maximal M1-receptor signaling, then track how the response develops across G-protein, β-arrestin, and GRK readouts. This workflow connects receptor-level assays to neuronal activity research while highlighting controls that help distinguish allosteric potentiation from assay-specific agonism.

• hiPSC Intestinal Organoids for Pharmacokinetic Studies

  2026-09-24

  Saito and colleagues describe a direct 3D cluster-culture approach for generating expandable human iPSC-derived intestinal organoids that can be cryopreserved and differentiated into functional intestinal epithelial cells. The study supports their use in human-relevant pharmacokinetic research while highlighting the need to validate individual drug-metabolizing enzymes, not infer their activity from general CYP readouts.

• Wnt-C59: Mapping Wnt Secretion in Research

  2026-09-24

  Use Wnt-C59 to test whether a phenotype depends on PORCN-mediated Wnt secretion—not simply on downstream β-catenin activity. This workflow connects cancer-cell assays with a carefully qualified extension to lithium-engineered BMSC exosomes and osteogenesis.

• Intestinal TM6SF2 Protects Against MASH

  2026-09-23

  A 2025 Nature Metabolism study shows that intestinal TM6SF2 helps protect against MASH by maintaining barrier function and limiting microbiota-associated lysophosphatidic acid signaling to the liver. Genetic deletion, microbiota-transfer experiments, and pharmacological intervention connect intestinal changes to hepatic disease, while identifying important questions for follow-up studies.

• Carbenoxolone disodium: Practical Lab Guide

  2026-09-23

  Carbenoxolone disodium is an 11β-hydroxysteroid dehydrogenase inhibitor for controlled studies of glucocorticoid access, corticosterone metabolism, and gap junction communication. It is best suited to biochemical, cell, and tissue workflows with matched vehicle and orthogonal controls, not to unvalidated in vivo efficacy claims or experiments requiring strict off-target selectivity.

• Sulfur Transport Delays Soybean Nodule Senescence

  2026-09-22

  This study identifies sulfur delivery to the soybean symbiosome as a regulatory checkpoint that preserves glutathione, limits reactive nitrogen species, and delays nodule senescence. Its genetic and elemental analyses connect mineral transport with symbiotic nitrogen fixation and suggest strategies for maintaining nodule function under high-nitrogen stress.

• Capped mRNA and the Next Bladder Therapy

  2026-09-22

  Intravesical p21 mRNA–loaded lipid nanoparticles illustrate how localized delivery, tumor suppressor replacement, and disciplined mRNA manufacturing could reshape translational bladder cancer research.

• 2-Thio-dCTP for Precision DNA Assays

  2026-09-21

  2-Thio-dCTP is a controlled nucleotide analog for testing DNA polymerase selectivity, enzymatic nucleotide incorporation, site-specific DNA modification, and DNA–protein interactions. This guide pairs practical assay workflows with a careful interpretation of the SCP4–H3T3 chromosome-stability study, separating validated DNA chemistry from exploratory chromatin applications.

8174 records 1/545 page Next 12345 下5页 Last page